Cochrane Abstracts
Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rituximab, Ofatumumab and Other Monoclonal anti-CD20 Antibodies for Chronic Lymphocytic Leukaemia: Cochrane Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437054/all/Rituximab__ofatumumab_and_other_monoclonal_anti_CD20_antibodies_for_chronic_lymphocytic_leukaemia:_Cochrane_systematic_review.
Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia: Cochrane systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437054/all/Rituximab__ofatumumab_and_other_monoclonal_anti_CD20_antibodies_for_chronic_lymphocytic_leukaemia:_Cochrane_systematic_review. Accessed April 29, 2025.
Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia: Cochrane systematic review. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437054/all/Rituximab__ofatumumab_and_other_monoclonal_anti_CD20_antibodies_for_chronic_lymphocytic_leukaemia:_Cochrane_systematic_review
Rituximab, Ofatumumab and Other Monoclonal anti-CD20 Antibodies for Chronic Lymphocytic Leukaemia: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 April 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437054/all/Rituximab__ofatumumab_and_other_monoclonal_anti_CD20_antibodies_for_chronic_lymphocytic_leukaemia:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia: Cochrane systematic review
ID - 437054
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437054/all/Rituximab__ofatumumab_and_other_monoclonal_anti_CD20_antibodies_for_chronic_lymphocytic_leukaemia:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
